https://www.selleckchem.com/pr....oducts/tubastatin-a.
At day ten and forward all patients were within target for treatment. No patients were at risk for toxic S-Se concentration. CONCLUSIONS S-Se concentration was substantially lower compared to normal values at intensive care unit admission in this cohort of unselected Swedish critical care patients. Selenium supplementation restituted S-Se to levels corresponding to enzymatic saturation and the Swedish reference interval for all subjects remaining in the ICU on day 5. This article is protected by copyright. All rights reserved.Lepto